rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    HRTX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      CorMedix to Acquire Heron Assets, Adding Four Products and Targeting Up to $60 Million in Savings
      Nov 10Yahoo FinanceCRMDHRTX
      Why Heron Therapeutics Stock is Surging on Monday - Heron Therapeutics (NASDAQ:HRTX), Cormedix (NASDAQ:CR
      Nov 9BenzingaCRMDHRTX
      12 Health Care Stocks Moving In Monday's Intraday Session
      Nov 9BenzingaEDSAHRTX
      Heron Therapeutics Reports 7.8% Decline in Q3 Revenue to $35.3 Million and Announces Proposed Asset Sale
      Nov 9Yahoo FinanceHRTX
      Heron Therapeutics earnings missed by $0.02, revenue fell short of estimates
      Nov 9Investing.comHRTX
      CorMedix stock gains as Heron deal adds four products

      Investing.com -- CorMedix Inc (NASDAQ:CRMD) shares rose 4.5% in premarket trading Monday after the company announced it will acquire substantially all assets of Heron Therapeutics Inc (NASDAQ:HRTX) for approximately $222.6 million. Heron stock surged 45% on the news.

      Nov 9Yahoo FinanceHRTX
      Heron Therapeutics Announces Third Quarter 2026 Financial Results
      Nov 9Yahoo FinanceHRTX
      Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates
      Nov 9Yahoo FinanceHRTX
      Heron Therapeutics: Q3 Earnings Snapshot
      Nov 9Yahoo FinanceHRTX
      CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care
      Nov 9Yahoo FinanceCRMDHRTX
      Heron Therapeutics to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
      Oct 27Yahoo FinanceHRTX
      Heron Therapeutics Expands U.S. Portfolio Through Licensing Deal

      Tipranks Press Release.

      Sep 30The Globe and MailHRTX
      Heron Therapeutics signs multi-product license agreement with Long Grove
      Sep 29Investing.comHRTX

      This is the newest page. Registered accounts read further back.